ZENAS BIOPHARMA, INC. (ZBIO) Technical Analysis
Updated: 2026-05-01 03:20 UTC · Last close: 19.32 (+10.09%) · Resistance: 19.37
ZENAS BIOPHARMA, INC. (ZBIO) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬆️ Resistance
19.37
🚀 Bullish Trigger
a clean close above 19.37 would strengthen the upside continuation case.
Quick Read
Compression note: triangle compression is around 68%, so resolution moves may become sharper as the structure tightens.
🔺 Technical Setup
Triangle
sym / bias UP
Compression
68%
RSI(14)
44.2
🎯 Decision Map
Compression note: triangle compression is around 68%, so resolution moves may become sharper as the structure tightens.
📊 Technical Summary
The latest close for ZENAS BIOPHARMA, INC. (ZBIO) came in at 19.32 (+10.09%). The chart is still trading below both the 50-day and 200-day moving averages, leaving the overall technical backdrop under pressure for now. 20-day momentum is running at -5.11%, with price remains inside its roughly 52-week range (8.68–43.17), while ATR14 volatility is elevated at roughly 6.29% of price. RSI(14) is 44.2, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Nearby upside pressure sits around 19.37. A decisive move through that level would improve the short-term picture. Fundamentals snapshot: Net income: -51.50M · EPS (basic): -1.22. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
ZENAS BIOPHARMA, INC.
CIK (SEC ID)
0001953926
Shares Out.
42.21M
Revenue
0.00
Net Income
-51.50M
EPS (Basic)
-1.22
Explore more
Note: This is an algorithmic technical snapshot (not financial advice).